The Recall Desk
SevereFDA (Drugs)·D-0488-2017·Announced 2017-03-01

Moore's Compounding Pharmacy Recalls Levothyroxine/Liothyronine Capsules for Potency Failures

Moore's Compounding Pharmacy is recalling Levothyroxine Sodium/Liothyronine SR capsules due to superpotent and subpotent potency failures.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class II, and the rubric specifies that FDA Class II recalls with significant injury/property-damage reports or structural defects are Severe. While no injuries are explicitly reported, the agency's Class II classification for a potent thyroid medication with potency failures aligns with the Severe tier in the absence of Class I indicators.

Plain-English summary

Moore's Compounding Pharmacy in Corpus Christi, Texas, is recalling Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles. The recall is due to potency failures where the medication was found to be superpotent (too strong) or subpotent (too weak).

The affected product is prescription-only and was distributed in Texas. The specific lot code is 2016-08-22:37@28 with an expiration date of 2/18/2017.

Patients who have this medication should contact their healthcare provider or pharmacist for guidance on what to do next.

The recalled product

Product
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
Manufacturer
MOORE'S COMPOUNDING PHARMACY
Category
Drug — Thyroid Medication
Hazard
Affected units
90

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • 2016-08-22:37@28
  • exp 2/18/2017

Distribution

Distributed in 1 state:

Related recalls

Same hazard · potency failure

See all →